247
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for pneumococcal pneumonia

, MD, , MD, , MD & , MD
Pages 459-477 | Published online: 12 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Susanna Esposito & Nicola Principi. (2013) Pharmacotherapy for pneumococcal infections: an update. Expert Opinion on Pharmacotherapy 14:1, pages 65-77.
Read now

Articles from other publishers (2)

Carrie D. Fischer, Stephanie C. Duquette, Bernard S. Renaux, Troy D. Feener, Douglas W. Morck, Morley D. Hollenberg, Merlyn J. Lucas & Andre G. Buret. (2014) Tulathromycin Exerts Proresolving Effects in Bovine Neutrophils by Inhibiting Phospholipases and Altering Leukotriene B 4 , Prostaglandin E 2 , and Lipoxin A 4 Production . Antimicrobial Agents and Chemotherapy 58:8, pages 4298-4307.
Crossref
Riana Cockeran, H. C. Steel, N. Wolter, L. de Gouveia, A. von Gottberg, K. P. Klugman, A. T. Leanord, D. J. Inverarity, T. J. Mitchell, C. Feldman & R. Anderson. (2012) Effects of Clarithromycin at Sub-Minimum Inhibitory Concentrations on Early <i>erm</i>B Gene Expression, Metabolic Activity and Growth of an <i>erm</i>(B)-Expressing Macrolide-Resistant Strain of <i>Streptococcus pneumoniae</i>. Open Journal of Respiratory Diseases 02:01, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.